GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.0200 $0.0500 Friday, 19th Apr 2024 CALA stock ended at $0.0251. During the day the stock fluctuated 0% from a day low at $0.0251 to a day high of $0.0251.
90 days $0.0200 $0.120
52 weeks $0.0100 $0.500

Historical Calithera Biosciences prices

Date Open High Low Close Volume
2024-03-14 $0.0200 $0.0200 $0.0200 $0.0200 5 628
2024-03-13 $0.0200 $0.0200 $0.0200 $0.0200 520
2024-03-12 $0.0251 $0.0251 $0.0251 $0.0251 153
2024-03-11 $0.0251 $0.0251 $0.0251 $0.0251 858
2024-03-08 $0.0200 $0.0200 $0.0200 $0.0200 2 080
2024-03-07 $0.0200 $0.0200 $0.0200 $0.0200 656
2024-03-06 $0.0200 $0.0200 $0.0200 $0.0200 422
2024-03-05 $0.0251 $0.120 $0.0200 $0.0200 3 340
2024-03-04 $0.0200 $0.0200 $0.0200 $0.0200 395
2024-03-01 $0.0200 $0.0200 $0.0200 $0.0200 379
2024-02-29 $0.0200 $0.0200 $0.0200 $0.0200 0
2024-02-28 $0.0200 $0.0200 $0.0200 $0.0200 540
2024-02-27 $0.0251 $0.0251 $0.0251 $0.0251 100
2024-02-26 $0.0200 $0.0251 $0.0200 $0.0251 1 460
2024-02-23 $0.0251 $0.0251 $0.0251 $0.0251 337
2024-02-22 $0.0251 $0.0251 $0.0200 $0.0251 791
2024-02-21 $0.0200 $0.0200 $0.0200 $0.0200 213
2024-02-20 $0.0300 $0.0300 $0.0300 $0.0300 0
2024-02-16 $0.0300 $0.0300 $0.0300 $0.0300 0
2024-02-15 $0.0300 $0.0300 $0.0300 $0.0300 0
2024-02-14 $0.0300 $0.0300 $0.0300 $0.0300 0
2024-02-13 $0.0300 $0.0300 $0.0300 $0.0300 4 033
2024-02-12 $0.0305 $0.0305 $0.0305 $0.0305 19 334
2024-02-09 $0.0301 $0.0301 $0.0301 $0.0301 255
2024-02-08 $0.0300 $0.0300 $0.0300 $0.0300 3 799
Click to get the best stock tips daily for free!

About Calithera Biosciences

Calithera Biosciences Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginas... CALA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT